A11- Notice of Intent to Sole Source.pdf

NOTICE OF INTENT

The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price contract to the manufacturer, Revvity Health Sciences, Inc for the purchase of the following items:

Product Name Mfr Part No Quantity Celigo Imaging Cytometer (5C Configuration)

200-BFFL-5C 1

On-site Installation-Training Celigo N0232089 1 Virology Application Suite License CLGASL8VIR 1

Only one responsible source and no other providers will satisfy agency requirements at this time due to the urgency of this need. The 5-channel configuration allows for multiplex assay development capable of detecting up to 4 targets simultaneously. This configuration offers expanded capabilities relative to the model already in-use. This model is pertinent to follow established laboratory SOPs that are already in place. Acquiring this make and model permits equipment redundancy across laboratory teams. To complete deliverables for projects, we must have this specific imaging cytometer with the 5-channel imaging configuration.

This contract action is for supplies for which the Government intends to solicit and negotiate with only one source under the authority of FAR 6.302-1. Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within seven (7) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist Ashley Williams at dal3@cdc.gov by 12:00 PM EST on August 23, 2024.